TaKaRa
Á¦Ç°¸í/Á¦Ç°ÄÚµå
Å°¿öµå°Ë»ö
°Ë»ö
´Ý±â
  • °í°´Áö¿ø 
  • ¾÷¹«¾È³»¦¢Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢02-2081-2510
  • Email     ¦¢support@takara.co.kr
  • ´ëÀüÁö»ç 
  • ¾÷¹«¾È³»¦¢´ëÀü/ÃæûÁö¿ª ÁÖ¹®, Á¦Ç°¹®ÀÇ
  • ÀüÈ­¹øÈ£¦¢042-828-6525
  • Email     ¦¢tkbd@takara.co.kr
  • ¾÷¹«½Ã°£¾È³»
  • [ Æò¡¡¡¡ÀÏ ] 09 : 00 ~ 18 : 00 ¦¢ [ Á¡½É½Ã°£ ] 12 : 00 ~ 13 : 00
  • Å䡤ÀÏ¿äÀÏ, °øÈÞÀÏÀº ÈÞ¹«ÀÔ´Ï´Ù.


event
 Á¦¸ñ : [À̺¥Æ® Á¾·á] [ÇÁ·Î¸ð¼Ç] Àúµ¶¼º, °íÈ¿À² Transfection ½Ã¾àÀ» ¼Ò°³ÇÕ´Ï´Ù. (20% ÇÒÀÎ Áß~)
ÀÛ¼ºÀÏ : 2024.05.16
 ÀÛ¼ºÀÚ : ´ÙÄ«¶óÄÚ¸®¾Æ

MirusÀÇ transfection ½Ã¾à (TransIT¢â ½Ã¸®Áî±â¼ú Ư¡

TransfectionÀº virus »ý»êºÎÅÍ CGT (Cell & Gene Therapy), ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê, CRISPR/Cas9µî ´Ù¾çÇÑ ½ÇÇè¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´ÙTransIT¢â ½Ã¸®Áî´Â polymer¿Í lipidÀÇ ÃÖÀûÈ­µÈ Á¶ÇÕÀ¸·Î Àúµ¶¼ºÀ̸鼭 °íÈ¿À²ÀÇ transfectionÀÌ °¡´ÉÇÏ¿© ´Ù¾çÇÑ cell°ú application¿¡ Àû¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

 

±×¸² 1. TransIT¢â ½Ã¸®ÁîÀÇ transfection ¿ø¸®

 

 

ÁÖ¿äÁ¦Ç° 3Á¾ ºñ±³

Mirus´Â ´Ù¾çÇÑ ½ÇÇè¿¡ ¸ÂÃç ÃÖÀûÈ­µÈ ½Ã¾àÀ» »ç¿ëÇÒ ¼ö ÀÖµµ·Ï ´Ù¾çÇÑ Á¦Ç°À» ÆǸÅÇÏ°í ÀÖ½À´Ï´ÙÀÌÁß °¡Àå ¹ü¿ëÀûÀ¸·Î »ç¿ëµÇ´Â º£½ºÆ®¼¿·¯ 3Á¾À» ¼Ò°³ÇÕ´Ï´Ù.

Ư¡

TransIT-X2¢ç Dynamic

Delivery System

(#MIR 6000)

TransIT¢ç -2020

Transfection Reagent

(#MIR 5400)

TransIT¢ç -LT1

Transfection Reagent

(#MIR 2300)

Àû¿ë

DNA, siRNA, miRNA, pre-miRNA

DNA only

DNA only

¼¼Æ÷ µ¶¼º

****

(Minimal Toxicity)

****

(Minimal Toxicity)

*****

(Exceptionally Low Toxicity)

Animal Origin Free

Yes

Yes

No

ÀåÁ¡

¹¹µçÁö Èֶѷ縶¶Ñ·ç

Hard to transfection

µ¶¼º¿¡ ¹Î°¨ÇÑ ¼¼Æ÷

 

 

Reagent Agent°¡ Á¦Ç° ¼±ÅÃÀ» µµ¿Íµå¸®°Ú½À´Ï´Ù.

Transfection ½Ã¾àÀÌ ³Ê¹« ¸¹¾Æ ¹«¾ùÀ» ¼±ÅÃÇÒÁö °í¹ÎÀΰ¡¿äCell type (e.g. HEK 293T, HeLa µî)°ú Nucleic Acid (e.g. Plasmid DNA, RNA µî)¸¦ ´ÙÄ«¶óÄÚ¸®¾Æ °í°´Áö¿ø (support@takara.co.kr)À¸·Î º¸³» Áֽøé ÃÖÀûÀÇ ½Ã¾à°ú citationÀ» ã¾Æµå¸³´Ï´Ù.

 

 

 

Á¦Ç° °ü·ÃµÈ ¹®ÀÇ»çÇ×Àº °í°´Áö¿ø (02-2081-2510, support@takara.co.kr·Î ¿¬¶ô ¹Ù¶ø´Ï´Ù  


÷ºÎÆÄÀÏ: TransIT¢â ½Ã¸®Á ¼Ò°³ÇÕ´Ï´Ù..pdf
 ¸ñ·ÏÀ¸·Î